Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7251 results

Sort By:

Study in Patients With Breast Cancer Leptomeningeal Metastasis

Study ID: NCT06638294
Start Date: 2024-11-25
End Date: 2028-12
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment
Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Source: clinicaltrials.gov

Share:
Add to list

Outcomes of Focal Ablation for Prostate Cancer

Study ID: NCT05478694
Start Date: 2023-02-01
End Date: 2026-08
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

225

Intervention / Treatment
Sponsor

University of Texas Southwestern Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Subcutaneous Talquetamab in Elderly Patients With Multiple Myeloma in Early Relapse

Study ID: NCT06827860
Start Date: 2025-06-01
End Date: 2028-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

23

Intervention / Treatment

Talkqueamab

DARATUMUMAB

Sponsor

Larysa Sanchez

Source: clinicaltrials.gov

Share:
Add to list

Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE Trial

Study ID: NCT04134260
Start Date: 2020-04-16
End Date: 2026-11-01
Study Type

Interventional

Study Phase

Phase3

No. of Participants

586

Intervention / Treatment

Apalutami

Biospecimen Collection

Bone Scan

Computed Tomography

Hormone Therapy

Magnetic Resonance Imaging

Positron Emission Tomography

Quality-of-Life Assessment

Administration questionnaire

Radiation Therapy

Sponsor

NRG Oncology

Source: clinicaltrials.gov

Share:
Add to list

At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer

Study ID: NCT05969860
Start Date: 2023-08-23
End Date: 2025-06-14
Study Type

Interventional

Study Phase

Phase2

No. of Participants

200

Intervention / Treatment

Clinical Encounter

Home Health Encounter

Quality-of-Life Assessment

Administration questionnaire

Sponsor

Mayo Clinic

Source: clinicaltrials.gov

Share:
Add to list

Thoracic Specimen Registry

Study ID: NCT04118660
Start Date: 2017-03-01
End Date: 2028-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

7000

Intervention / Treatment

Tissue Banking

Sponsor

Mayo Clinic

Source: clinicaltrials.gov

Share:
Add to list

A Study of Vemurafenib and Obinutuzumab Compared to Cladribine and Rituximab in People with Hairy Cell Leukemia (HCL)

Study ID: NCT06561360
Start Date: 2024-09-09
End Date: 2027-09-09
Study Type

Interventional

Study Phase

Phase2

No. of Participants

86

Intervention / Treatment

Rampheinibi

Obinutuzumab

Cladribine

Rituximab

Sponsor

Memorial Sloan Kettering Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia

Study ID: NCT04811560
Start Date: 2021-05-19
End Date: 2027-10-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

400

Intervention / Treatment

Bleximenib

Sponsor

Janssen Research & Development, LLC

Source: clinicaltrials.gov

Share:
Add to list

Telephone-Based Intervention in Increasing Adherence to Adjuvant Hormonal Therapy in Patients with Breast Cancer

Study ID: NCT02400060
Start Date: 2015-03-26
End Date: 2026-08-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

314

Intervention / Treatment

Telephone-Based Intervention

Survey Administration

Laboratory Biomarker Analysis

Sponsor

Ohio State University Comprehensive Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Early Onset Colorectal Cancer Detection

Study ID: NCT06342401
Start Date: 2023-04-15
End Date: 2025-10-15
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

400

Intervention / Treatment

ENCODE

Sponsor

City of Hope Medical Center

Source: clinicaltrials.gov

Share:
Add to list